Zilebesiranhypertensioncardiovascular diseasePubMedCochrane Library
…h concern and a leading risk factor for cardiovascular disease. Zilebesiran, an investigational RNA interference therapeutic, aims to reduc…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…h concern and a leading risk factor for cardiovascular disease. Zilebesiran, an investigational RNA interference therapeutic, aims to reduc…